» Authors » Maria Giulia Vincini

Maria Giulia Vincini

Explore the profile of Maria Giulia Vincini including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 35
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Volpe S, Vincini M, Zaffaroni M, Gaeta A, Raimondi S, Piperno G, et al.
Cancers (Basel) . 2025 Mar; 17(5). PMID: 40075755
An Early-Stage Non-Small Cell Lung Cancer (ES-NSCLC) patient candidate for stereotactic body radiotherapy (SBRT) may start their treatment without a histopathological assessment, due to relevant comorbidities. The aim of this...
2.
Corrao G, Marvaso G, Zaffaroni M, Vincini M, Badellino S, Borghetti P, et al.
Radiol Med . 2025 Mar; PMID: 40072805
Aim: Despite the widespread use of immunotherapy (IO) and targeted therapy (TT) in clinical practice, data on toxicity in combination with SBRT are lacking, largely based on retrospective studies and...
3.
Marvaso G, Corrao G, Zaffaroni M, Vincini M, Lorubbio C, Gandini S, et al.
Lancet Oncol . 2025 Mar; 26(3):300-311. PMID: 40049196
Background: Metastasis-directed therapy by stereotactic body radiotherapy (SBRT) has been shown to improve clinical outcomes in the oligometastatic prostate cancer setting. We aimed to investigate whether short-course androgen deprivation therapy...
4.
Alterio D, Gola M, Zaffaroni M, Vincini M, Cattaneo C, Aristei C, et al.
Clin Transl Oncol . 2025 Mar; PMID: 40048019
Background: Human papilloma virus (HPV)-related cancers are well-known clinical entities in different body sites. Cervix, anus, and oropharynx are the most common tumors related to the virus infection. The aim...
5.
Burla T, Zaffaroni M, Marvaso G, Mazzocco K, Galli G, Vincini M, et al.
Tumori . 2025 Feb; :3008916251317093. PMID: 39924662
Purpose: Professional quality of life (QoL) is crucial for healthcare workers as it affects performance at work and interaction with patients, but little is known about stressors influencing radiation oncology...
6.
Rutkowski K, Gola M, Godlewski J, Starzynska A, Marvaso G, Mastroleo F, et al.
Oncol Rev . 2025 Feb; 18:1514004. PMID: 39906323
Worldwide, head and neck cancers (HNCs) account for approximately 900,000 cases and 500,000 deaths annually, with their incidence continuing to rise. Carcinogenesis is a complex, multidimensional molecular process leading to...
7.
Volpe S, Mastroleo F, Vincini M, Zaffaroni M, Porazzi A, Damiani E, et al.
Crit Rev Oncol Hematol . 2024 Sep; 204:104500. PMID: 39245297
Purpose: To focus on the ecological footprint of radiotherapy (RT), on opportunities for sustainable practices, on future research directions. Methods: Different databases were interrogated using the following terms: Carbon Footprint,...
8.
Isaksson L, Mastroleo F, Vincini M, Marvaso G, Zaffaroni M, Gola M, et al.
Crit Rev Oncol Hematol . 2024 Sep; 204:104485. PMID: 39233128
Artificial intelligence (AI) has made a tremendous impact in the space of healthcare, and proton therapy is not an exception. Proton therapy has witnessed growing popularity in oncology over recent...
9.
Leonardi M, Arculeo S, Frassoni S, Zerella M, Gerardi M, Fodor C, et al.
Pract Radiat Oncol . 2024 Jul; 15(1):31-47. PMID: 39069002
Purpose: To evaluate the outcome of partial breast reirradiation (re-PBI) with intensity modulated radiation therapy using a hypofractionated scheme for breast cancer (BC) local relapse (LR) operated on with repeat...
10.
Santamaria R, Zaffaroni M, Vincini M, Colombi L, Gaeta A, Mastroleo F, et al.
Life (Basel) . 2024 Jul; 14(7). PMID: 39063623
Materials And Methods: Eighty-six patients who underwent SBRT for macroscopic bed recurrence after prostatectomy were retrospectively included. Patients were treated based on mpMRI or choline/PSMA PET. Results: The median time...